Members |
targetComponentId |
Allergy to vitamin supplement |
Allergy to vitamin D and/or vitamin D derivative |
Allergy to vitamin supplement |
Allergy to retinol (finding) |
Allergy to wood |
Allergy to wood dust (finding) |
Allergy to yeast antigen |
Allergy to yeast (finding) |
Allergy to zinc |
Allergy to zinc and/or zinc compound (finding) |
Allomonas species |
Allomonas |
Alloplastic grafting |
Grafting - action |
Alopecia areata (& ophiasis) |
Alopecia areata (disorder) |
Alopecia areata (& ophiasis) |
Ophiasis |
Alopecia cicatrisata |
Pseudopelade |
Alopecia cicatrisata |
Scarring alopecia (disorder) |
Alopecia parvimaculata |
Scarring alopecia (disorder) |
Alpha blocking vasodilator |
Product containing alpha adrenergic receptor antagonist (product) |
Alpha thalassaemia (& homozygous) |
Homozygous alpha thalassemia |
Alpha thalassaemia (& homozygous) |
Alpha thalassemia (disorder) |
Alpha thalassemia-mental retardation syndrome |
A rare X-linked syndromic intellectual disability characterized by profound developmental delay, facial dysmorphism, genital abnormalities and alpha thalassemia. |
Alpha thalassemia-mental retardation syndrome |
A rare developmental defect during embryogenesis, a contiguous gene deletion syndrome, is a form of alpha-thalassemia characterized by microcytosis, hypochromia, normal hemoglobin (Hb) level or mild anemia, associated with developmental abnormalities. |
Alpha-feto protein blood test (& [antenatal]) |
Alpha-fetoprotein test - antenatal |
Alpha-feto protein blood test (& [antenatal]) |
Alpha-fetoprotein test - antenatal |
Alpha-feto protein blood test (& [antenatal]) |
Alpha-fetoprotein blood test |
Alpha-feto protein blood test (& [antenatal]) |
Alpha-fetoprotein blood test |
Alpha-glucoside inhibitor |
Substance with alpha-glucosidase inhibitor mechanism of action (substance) |
Alpha/beta lipoproteinemia |
Hyperalphalipoproteinemia |
Alpha/beta lipoproteinemia |
Primary combined hyperlipidaemia |
Alpha/beta-adrenergic blocking agent |
Product containing alpha adrenergic receptor antagonist (product) |
Alpha/beta-adrenergic blocking agent |
Product containing adrenergic neurone blocker (product) |
Alpha/beta-adrenergic blocking agent |
Product containing beta adrenergic receptor antagonist (product) |
Alphavirus |
Arbovirus |
Alphavirus |
Alphavirus |
Alport syndrome-like hereditary nephritis |
Hereditary nephritis (disorder) |
Alport syndrome-like hereditary nephritis |
A rare renal disease characterized by glomerular nephropathy with hematuria progressing to end-stage renal disease (ESRD), frequently associated with sensorineural deafness, and occasionally with ocular anomalies. |
Alport's syndrome |
Thin basement membrane disease |
Alport's syndrome |
Thin basement membrane disease |
Alport's syndrome |
Thin basement membrane disease |
Alprazolam 1mg/ml concentrate |
Product containing precisely alprazolam 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Alprostadil 1000mcg suppository |
Product containing precisely alprostadil 1 milligram/1 each conventional release urethral stick (clinical drug) |
Alprostadil 1000micrograms pellet |
Product containing precisely alprostadil 1 milligram/1 each conventional release urethral stick (clinical drug) |
Alprostadil 10micrograms injection (pdr for recon) |
Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
Alprostadil 10micrograms injection (pdr for recon) |
Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Alprostadil 10micrograms injection (pdr for recon) |
Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Alprostadil 10micrograms injection (pdr for recon) |
Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
Alprostadil 10micrograms injection cartridge starter pack |
Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
Alprostadil 10micrograms powder and solvent for injection solution cartridge |
Product containing precisely alprostadil 10 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
Alprostadil 10micrograms powder and solvent for injection solution vial |
Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Alprostadil 125mcg suppository |
Alprostadil 125 microgram urethral stick |
Alprostadil 125micrograms pellet |
Alprostadil 125 microgram urethral stick |
Alprostadil 20micrograms injection (pdr for recon) |
Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
Alprostadil 20micrograms injection (pdr for recon) |
Alprostadil 20 microgram powder for solution for injection vial |
Alprostadil 20micrograms injection (pdr for recon) |
Alprostadil 20 microgram powder for solution for injection vial |
Alprostadil 20micrograms injection cartridge starter pack |
Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
Alprostadil 20micrograms powder and solvent for injection solution cartridge |
Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug) |
Alprostadil 20micrograms powder and solvent for injection solution vial |
Alprostadil 20 microgram powder for solution for injection vial |
Alprostadil 250mcg suppository |
Alprostadil 250 microgram urethral stick |
Alprostadil 250micrograms pellet |
Alprostadil 250 microgram urethral stick |
Alprostadil 40micrograms powder and solvent for injection solution vial |
Alprostadil 40 microgram powder for solution for injection vial |
Alprostadil 500mcg suppository |
Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug) |
Alprostadil 500micrograms pellet |
Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug) |
Alprostadil 5mcg/mL powder |
Alprostadil 5 microgram powder for solution for injection vial |
Alprostadil 5micrograms powder and solvent for injection solution vial |
Alprostadil 5 microgram powder for solution for injection vial |
Alteplase 10mg powder and solvent for injection solution vial |
Alteplase 10 mg powder for solution for injection vial |
Alteplase 20mg powder and solvent for injection solution vial |
Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Alteplase 50mg powder and solvent for injection solution vial |
Product containing precisely alteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Alteration in nutrition: potential for more than body requirements |
Future energy intake that is anticipated, based on observation, experience, or scientific reason, to exceed estimated energy expenditure, established reference standards, or recommendations based on physiological needs. |
Alteration in nutrition: potential for more than body requirements |
At increased risk of food intake greater than requirement |
Alteration in nutrition: potential for more than body requirements |
Future nutrient intake that is anticipated, based on observation, experience, or scientific reason, to exceed estimated nutrient requirement, established reference standards, or recommendations based on physiological needs. |
Alteration in parenting |
Impaired parenting (finding) |
Alteration in parenting |
Alteration in parenting (finding) |
Ineffective tissue perfusion (specify type) |
Alteration in tissue perfusion (finding) |
Ineffective tissue perfusion (specify type) |
Ineffective tissue perfusion (finding) |
Alternating-pressure bed mattress overlay, reusable |
Alternating-pressure bed mattress overlay system |
Alternating-pressure bed mattress overlay, single-use |
Alternating-pressure bed mattress overlay system |
Alternating-pressure chair cushion, reusable |
Alternating-pressure chair cushion system |
Alternating-pressure chair cushion, single-use |
Alternating-pressure chair cushion system |
Alternative-complement-pathway C3/C5 convertase |
Active C3bBbC3b |
Alternative-complement-pathway C3/C5 convertase |
Active C3bBb |
Altitude edema |
High altitude cerebral edema |
Altitude edema |
High altitude pulmonary oedema |
Altitudinal hemianopsia |
Altitudinal hemianopia |
Altitudinal hemianopsia |
Altitudinal scotoma |
Aluminum astringent adverse reaction |
Adverse reaction to aluminium and/or aluminium compound |
Aluminum chloride 20% roll-on application |
Aluminium chloride 200 mg/mL cutaneous solution |
Aluminum chloride 20% roll-on solution |
Aluminium chloride 200 mg/mL cutaneous solution |
Aluminum hydroxide+belladonna |
Product containing aluminium hydroxide and belladonna alkaloid (medicinal product) |
Aluminum intoxication |
Aluminium and/or aluminium compound poisoning (disorder) |
Alveolitis of jaw NOS |
Infection of tooth socket (disorder) |
Always eating |
Excessive eating |
Always eating |
Always eating |
Alysiella species |
Alysiella |
Amantadine hydrochloride 50mg/5 mL syrup |
Amantadine hydrochloride 10 mg/mL oral solution |
Amantadine hydrochloride 50mg/5mL syrup |
Amantadine hydrochloride 10 mg/mL oral solution |
Amantadine hydrochloride 50mg/5mL syrup |
Amantadine hydrochloride 10 mg/mL oral solution |
Amaranthus palmeri pollen allergen |
Amaranthus palmeri pollen |
Amazona ochrocephala oratrix |
Amazona oratrix (organism) |
Amazona ochrocephala oratrix |
Amazona oratrix subspecies oratrix (organism) |
Amazona ochrocephala oratrix |
Amazona ochrocephala |
Amblyopia |
Amblyopia (disorder) |
Amblyopia |
Functional amblyopia (disorder) |
Amblyopia: [unspecified] or [congenital] |
Amblyopia (disorder) |
Amblyopia: [unspecified] or [congenital] |
Functional amblyopia (disorder) |
Ambrosia artemisiifolia pollen allergen |
Ambrosia artemisiifolia pollen (substance) |
Ambrosia psilostachya pollen allergen |
Ambrosia psilostachya pollen |